Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-08-26

Clinical Trial Update: Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing carboplatin with or without thalidomide in ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPLATIN (Carboplatin)
  • Thalidomide (thalidomide)

Snippet

Sponsor: Cancer Research UK | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED